Thomas Stephan
Stock Analyst at Stifel
(1.41)
# 3,546
Out of 5,006 analysts
47
Total ratings
36.67%
Success rate
-9.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Maintains: Buy | $90 → $85 | $75.96 | +11.90% | 5 | Sep 29, 2025 | |
| TMDX TransMedics Group | Initiates: Hold | $115 | $118.32 | -2.81% | 1 | Sep 4, 2025 | |
| STAA STAAR Surgical Company | Downgrades: Hold | $20 → $28 | $26.69 | +4.91% | 10 | Aug 7, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $84.87 | +35.50% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $8.35 | +235.33% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $3.30 | +21.40% | 7 | Mar 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $14.72 | +22.28% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.13 | +76.99% | 2 | May 15, 2024 |
Alcon
Sep 29, 2025
Maintains: Buy
Price Target: $90 → $85
Current: $75.96
Upside: +11.90%
TransMedics Group
Sep 4, 2025
Initiates: Hold
Price Target: $115
Current: $118.32
Upside: -2.81%
STAAR Surgical Company
Aug 7, 2025
Downgrades: Hold
Price Target: $20 → $28
Current: $26.69
Upside: +4.91%
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $84.87
Upside: +35.50%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $8.35
Upside: +235.33%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.30
Upside: +21.40%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $14.72
Upside: +22.28%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.13
Upside: +76.99%